OPTIMUS: establishing international consensus on user-reported outcomes for opioid agonist maintenance treatment

The OPTIMUS* study group aims to establish international consensus guidance on monitoring user-reported outcomes for opioid agonist maintenance treatment. On this page you can find the OPTIMUS consensus guidance and further information on ongoing activities, including background, resources, events, news and more.

*OPTIMUS: OPioid Treatment outcomes Interview for Maintenance medication USers

Logo of the optimus project showing coloure shapes on a mosaic

Overview

The OPTIMUS study group, coordinated by the EUDA, aims to establish international consensus on monitoring user-reported outcomes for opioid agonist maintenance treatment (OMT).

Through a two-round Delphi study involving 757 participants from 26 countries, a six-domain OMT outcomes questionnaire was developed, covering treatment, physical and mental health, social functioning, substance use, and quality of life.

The tool, endorsed by both professionals and service users, has been translated into 21 languages and refined based on extensive feedback. Feasibility testing, currently ongoing, evaluates acceptability and implementation in OMT services. OPTIMUS promotes harmonised, user-centred measurement of public health relevant OMT outcomes in order to help save and improve service users' lives.

OPTIMUS guidance

In this section you can find the OPTIMUS guidance (consisting of parts A and B). Both documents are updated on an ongoing basis.

Collaborating in the OPTIMUS group

Colleagues and people with lived experience from any country interested in collaborating in the OPTIMUS group, in particular the ongoing feasibility testing study, are welcome to contact us.

OPTIMUS scientific publications and other outputs

In the list below, you can find articles published in the scientific papers from the collaboration as well as other outputs related to the project.

 

 

 

Top